Where do we go from here? The evolving landscape of molecular diagnostics

Bloomberg BNA Life Sciences Law & Industry Report
By:
In this article, we report on the diverse perspectives offered by representatives from the public and private sector working in the field of how the recent evolution in case law has affected the molecular diagnostics industry and how it may impact strategies moving forward.

Reproduced with permission from Life Sciences Law & Industry Report, 10 LSLR 13, 06/24/2016. Copyright 2016 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com